Gastrointestinal Disease

The Gastrointestinal (GI) Group focuses its discovery efforts on developing new and safer therapies for inflammatory and functional disorders of the GI tract.

The GI research strategy focuses on gaining a better understanding of the genetic basis of GI diseases (e.g., Crohn’s disease) and the pathophysiology associated with these diseases, including mucosal barrier function and innate immunity, and on neural control of motility and perception.

GI concentrates on inflammatory bowel diseases such as Crohn’s Disease and ulcerative colitis, as well as irritable bowel syndrome and gastroparesis.